🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Hemab Therapeutics Holdings, Inc.

COAG Healthcare
$35.08 $-0.26 (-0.74%)
Market Cap: $1.64 B
Gurus Holding
1
Popularity Rank
#4819
% of Shares Held
0.05%
Net Activity (Q2 2026)
+$918,250

Guru Ownership Trend

Guru Analysis for Hemab Therapeutics Holdings, Inc. (COAG)

Hemab Therapeutics Holdings, Inc. (COAG), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $877,000.

Top institutional holders include George Soros.

Institutional sentiment is currently Bullish. This is evidenced by a $918,250 net inflow during the quarter.

Recent activity highlights George Soros who opened a new position.

Key Holders

Top 5 by Value

$918,250

Top 5 by Conviction

0.01%

Recent Activity Breakdown (Q2 2026)

+$918,250
Total Buy Value
New Buys 1
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
0
Net Buyers
1

FAQs for Hemab Therapeutics Holdings, Inc. (COAG)

Major holders include George Soros ($918,250). According to the latest reported data, 1 tracked investment managers collectively hold approximately 25,000 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $918,250, with 1 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in COAG during the most recent reporting period.

Yes, 1 managers opened new positions in COAG, and 0 increased their existing holdings. The total reported buy value was $918,250.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% New Buy 25,000 $918,250 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form